Sponsor Pipeline

HonorHealth Research Institute Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07463599 Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma Metastatic Colorectal Carcinoma (mCRC) Recruiting
Disease Areas
Colorectal Cancer (1)
Get alerts when HonorHealth Research Institute's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free